Tubeimoside III inhibits lipopolysaccharide-induced inflammatory responses by reprogramming glycolytic metabolism
Yushi Lina,b, , Hongyi Yuea,b, ,Pingyi Wang a,b,Yimei Lia,b,Dan Song a ,b,*,Wenhua Li a,b,*
Engineering Research Center of Tibetan Medicine Detection Technology, Ministry of Education, School of Medicine, Xizang Minzu University, Xianyang 712082, Shaanxi, China.
Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang 712082, Shaanxi, China. ✝.Yushi Lin and Hongyi Yue have contributed equally to this work and share first authorship.
*. Correspondence to: School of Medicine, Xizang Minzu University, Xianyang 712082, China. E-mail address: xzmylwh@163.com (Wenhua Li), dsong@xzmu.edu.cn (Dan Song).